This page shows the latest Cepheid news and features for those working in and with pharma, biotech and healthcare.
Another coronavirus test, developed by California, US-based Cepheid, was approved by the US Food and Drug Administration (FDA) earlier this week.
Cepheid revealed in a statement issued on Saturday that the tests will begin shipping this week, with plans to make the point-of-care diagnostics available by 30 March. ... The approval of Cepheid’s test comes as criticism grows over how the US is
Major diagnostics companies such as Alere, Abbott, BD Diagnostics, Cepheid and Abaxis have started to realise the potential of rapid molecular diagnostic testing and are making inroads into the market.
of things, including a partnership with Cepheid and AstraZeneca to develop a rapid diagnostic test to detect the presence of bacteria.
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
ROAD is a digital PR and communications consultancy specialising in promoting the innovators that shape our future health and wellbeing....